Ian Portek

1.7k total citations
24 papers, 1.3k citations indexed

About

Ian Portek is a scholar working on Rheumatology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Ian Portek has authored 24 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Rheumatology, 9 papers in Surgery and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Ian Portek's work include Rheumatoid Arthritis Research and Therapies (8 papers), Systemic Lupus Erythematosus Research (5 papers) and Musculoskeletal synovial abnormalities and treatments (4 papers). Ian Portek is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (8 papers), Systemic Lupus Erythematosus Research (5 papers) and Musculoskeletal synovial abnormalities and treatments (4 papers). Ian Portek collaborates with scholars based in Australia, United Kingdom and United States. Ian Portek's co-authors include Mark J. Pearcy, Marissa Lassere, Bruce Kirkham, John Edmonds, Ron Shnier, Paul Bird, Sabrina M. Chase, J. A. Klaber Moffett, A G Mowat and Zoltan Szomor and has published in prestigious journals such as Spine, Arthroscopy The Journal of Arthroscopic and Related Surgery and Osteoarthritis and Cartilage.

In The Last Decade

Ian Portek

24 papers receiving 1.3k citations

Peers

Countries citing papers authored by Ian Portek

Since Specialization

Citations

This map shows the geographic impact of Ian Portek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Portek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Portek more than expected).

Fields of papers citing papers by Ian Portek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Portek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Portek. The network helps show where Ian Portek may publish in the future.

Co-authorship network of co-authors of Ian Portek

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Portek. A scholar is included among the top collaborators of Ian Portek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Portek. Ian Portek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Individualising the dose of allopurinol in patients with gout 2017 ·British Journal of Clinical Pharmacology ·Diluk R. W. Kannangara, Garry G. Graham, Daniel F. B. Wright, Sophie L. Stocker, Ian Portek, Kevin D. Pile, Murray L. Barclay, Kenneth M. Williams, Lisa K. Stamp, Richard O. Day	16
2	Understanding the dose–response relationship of allopurinol: predicting the optimal dosage 2013 ·British Journal of Clinical Pharmacology ·Garry G. Graham, Diluk R. W. Kannangara, Sophie L. Stocker, Ian Portek, Kevin D. Pile, Praveen Indraratna, (unknown), Kenneth M. Williams, Richard O. Day	30
3	Australian and New Zealand national evidence-based recommendations for the investigation and follow-up of undifferentiated peripheral inflammatory arthritis: an integration of systematic literature research and rheumatological expert opinion 2013 ·International Journal of Rheumatic Diseases ·Claire Barrett, Paul Bird, Gabor Major, Evange Romas, Ian Portek, Andrew Taylor, Jane Zochling	2
4	How many life years are lost in patients with rheumatoid arthritis? Secular cause‐specific and all‐cause mortality in rheumatoid arthritis, and their predictors in a long‐term Australian cohort study 2012 ·Internal Medicine Journal ·Marissa Lassere, (unknown), Ian Portek, Allan Sturgess, John Edmonds	50
5	Fractional clearance of urate: validation of measurement in spot-urine samples in healthy subjects and gouty patients 2012 ·Arthritis Research & Therapy ·Diluk R. W. Kannangara, (unknown), Praveen Indraratna, Sophie L. Stocker, Garry G. Graham, Graham Jones, Ian Portek, Kenneth M. Williams, Richard O. Day	26
6	Effect of treatment with biological agents for arthritis in Australia: the Australian Rheumatology Association Database 2007 ·Internal Medicine Journal ·Rachelle Buchbinder, Lyn March, Marissa Lassere, Andrew M. Briggs, Ian Portek, Christopher M. Reid, Adrian D. Meehan, Luke A. Henderson, (unknown), (unknown)	31
7	Arthroscopic estimation of the extent of chondropathy 2006 ·Osteoarthritis and Cartilage ·S. P. Oakley, Ian Portek, Zoltan Szomor, Richard Appleyard, P. Ghosh, Bruce Kirkham, George A.C. Murrell, Marissa Lassere	7
8	Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: A two‐year prospective study (the DAMAGE study cohort) 2006 ·Arthritis & Rheumatism ·Bruce Kirkham, Marissa Lassere, John Edmonds, (unknown), Paul Bird, (unknown), Ron Shnier, Ian Portek	276
9	Arthroscopy – a potential “gold standard” for the diagnosis of the chondropathy of early osteoarthritis 2005 ·Osteoarthritis and Cartilage ·S. P. Oakley, Ian Portek, Zoltan Szomor, Richard Appleyard, P. Ghosh, Bruce Kirkham, George A.C. Murrell, Marissa Lassere	49
10	Biomechanical, histologic and macroscopic assessment of articular cartilage in a sheep model of osteoarthritis 2004 ·Osteoarthritis and Cartilage ·S. P. Oakley, Marissa Lassere, Ian Portek, Zoltan Szomor, P. Ghosh, Bruce Kirkham, George A.C. Murrell, (unknown), Richard Appleyard	60
11	Documenting damage progression in a two‐year longitudinal study of rheumatoid arthritis patients with established disease (the DAMAGE study cohort): Is there an advantage in the use of magnetic resonance imaging as compared with plain radiography? 2004 ·Arthritis & Rheumatism ·Paul Bird, Bruce Kirkham, Ian Portek, Ron Shnier, Fredrick Joshua, John Edmonds, Marissa Lassere	21
12	Accuracy and reliability of arthroscopic estimates of cartilage lesion size in a plastic knee simulation model 2003 ·Arthroscopy The Journal of Arthroscopic and Related Surgery ·S. P. Oakley, Ian Portek, Zoltan Szomor, (unknown), George A.C. Murrell, Bruce Kirkham, Marissa Lassere	18
13	Intraarticular variability of synovial membrane histology, immunohistology, and cytokine mRNA expression in patients with rheumatoid arthritis. 1999 ·PubMed ·B. W. Kirkham, Ian Portek, (unknown), (unknown), (unknown), Marissa Lassere, John Edmonds	41
14	Septic arthritis of the shoulder after mastectomy and radiotherapy for breast carcinoma 1993 ·Journal of Bone and Joint Surgery - British Volume ·К. Ray Chaudhuri, (unknown), Ian Portek, L McGuigan	13
15	The Effect of Low-Back Pain on Lumbar Spinal Movements Measured by Three-Dimensional X-Ray Analysis 1985 ·Spine ·Mark J. Pearcy, Ian Portek, (unknown)	142
16	Spinal Movements in Ankylosing Spondylitis and the Effect of Treatment 1985 ·Spine ·Mark J. Pearcy, B P Wordsworth, Ian Portek, A G Mowat	6
17	Clinical features and followup study of HLA-B27 positive patients presenting with peripheral arthritis. 1985 ·PubMed ·P. Sambrook, L McGuigan, G. David Champion, John Edmonds, Adam Fleming, Ian Portek	13
18	Three-Dimensional X-ray Analysis of Normal Movement in the Lumbar Spine 1984 ·Spine ·Mark J. Pearcy, Ian Portek, (unknown)	314
19	CORRELATION BETWEEN RADIOGRAPHIC AND CLINICAL MEASUREMENT OF LUMBAR SPINE MOVEMENT 1983 ·Lara D. Veeken ·Ian Portek, Mark J. Pearcy, (unknown), A G Mowat	75
20	Clinical significance of immune complexes in rheumatoid disease. 1981 ·PubMed ·A Fleming, J. A. Charlesworth, May Y. Liew, Ian Portek, J V Bertouch, (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact